Articles

Poll

Podcasts

Slideshows

Videos

The Contemporary Pediatrics Editor-in-Chief reviews the pharmacological breakthroughs and epidemiological setbacks that defined RSV in 2023.

A Year of RSV Highs and Lows, with Tina Tan, MD

Lungcast is joined by an environmental engineer to discuss the burden of harmful air in US school systems today.

Why Good Indoor Air Quality Matters with Mark Hernandez, PhD, PE

These new data highlight key points about the timeline of benefits for those who quit smoking cigarettes, including respiratory and cardiovascular benefits.


New Findings Identified Regarding Time Scale of Benefits for Individuals Quitting Smoking 

This news from the FDA followed a resubmission after the FDA’s complete response letter for the P2X3 receptor antagonist’s use in refractory chronic cough and unexplained cough.

FDA Advisory Committee Votes Against Gefapixant for Chronic Cough in Adult Patients

For Lung Cancer Awareness Month, Lungcast speaks with Christy Fischer, a patient who's spent the last 17 years fighting late-stage cancer. 

The Four-Time Stage IV Lung Cancer Patient

This new data indicates both the high mental health burden on this patient population as well as the usefulness of integrated behavioral health care teams in clinics with a pediatric specialty.


Prevalence of Anxiety, Depression Assessed for Pediatric High-Risk Asthma Patients

This new data suggests that hospital facilities in the US may need to plan for potentially atypical timing of bronchiolitis season once more for 2023.


Pandemic-Era Bronchiolitis Admissions Found Not to Have Decreased to Pre-Pandemic Levels

This new research sheds light on the importance of follow-up meetings for young patients discharged from emergency departments.


Half of Children Under 2 Years with Acute Bronchiolitis Followed Up After Initial Visits

Though primarily observational, this research’s biggest asset is its experimental design and its exploration of viral stimulus-induced bronchial epithelial cell responses from asthmatic donors being treated with tezepelumab.


Tezepelumab Helps to Stabilize Bronchial Epithelial Immune Response to Respiratory Viruses

This newly-developed prediction model evaluating CAP risk was noted as having demonstrated accuracy, strong discriminatory qualities, and practicability in clinical settings.

Prediction Model Effective for Community-Acquired Pneumonia in Those with Acute Asthma Exacerbations

Lung Cancer

Pulmonary Fibrosis

Asthma

The HCPLive asthma page is a comprehensive resource for clinical news and insights on asthmatic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for allergic and severe asthma, and more.

COPD

COPD condition center page, resources on the topics of medical news and expert insight into chronic obstructive pulmonary disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on COPD research, treatment, and drug development.

Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.

Pulmonology